Mucositis in malignant hematology.

  title={Mucositis in malignant hematology.},
  author={Pasquale Niscola},
  journal={Expert review of hematology},
  volume={3 1},
Mucosal barrier injury (MBI), also known as mucositis, is the result of the cytotoxic effects of many treatments given for hematological malignancies (HMs) and represents a major source of potentially devastating clinical complications and negative consequences afflicting the patient's management, such as a longer hospitalization, the need of analgesic and total parenteral nutrition use, and increased costs. The available measures for the prevention and treatment of MBI have been substantially… CONTINUE READING


Publications citing this paper.
Showing 1-2 of 2 extracted citations


Publications referenced by this paper.
Showing 1-10 of 78 references

Similar Papers

Loading similar papers…